| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.27B | 12.48B | 11.96B | 10.78B | 7.95B | 6.08B |
| Gross Profit | 8.31B | 7.70B | 6.96B | 6.90B | 6.96B | 5.97B |
| EBITDA | 2.86B | 2.69B | 3.02B | 3.18B | 3.25B | 1.98B |
| Net Income | 2.21B | 2.21B | 1.94B | 1.95B | 2.24B | 1.29B |
Balance Sheet | ||||||
| Total Assets | 285.37B | 225.11B | 204.23B | 189.37B | 182.91B | 174.06B |
| Cash, Cash Equivalents and Short-Term Investments | 37.65B | 27.91B | 17.21B | 13.70B | 7.43B | 6.29B |
| Total Debt | 23.47B | 18.48B | 16.57B | 13.01B | 11.71B | 7.44B |
| Total Liabilities | 252.79B | 200.73B | 184.45B | 169.97B | 165.14B | 154.75B |
| Stockholders Equity | 32.53B | 24.34B | 19.74B | 19.35B | 17.73B | 19.30B |
Cash Flow | ||||||
| Free Cash Flow | 2.21B | 2.28B | 1.67B | 2.52B | 3.81B | 1.81B |
| Operating Cash Flow | 2.39B | 2.54B | 1.81B | 2.66B | 4.03B | 2.06B |
| Investing Cash Flow | -4.80B | -8.38B | -12.12B | -3.00B | -11.61B | -3.96B |
| Financing Cash Flow | 6.28B | 6.49B | 13.02B | 3.77B | 8.76B | 827.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $23.63B | 10.08 | 11.78% | 3.74% | 2.92% | 16.52% | |
74 Outperform | $85.75B | 10.39 | 12.22% | 3.77% | 3.87% | 18.20% | |
72 Outperform | $32.76B | 13.98 | 8.82% | 3.50% | 9.10% | 0.60% | |
71 Outperform | $44.73B | 58.08 | 8.86% | 3.14% | 7.66% | -5.41% | |
70 Outperform | $23.23B | 10.41 | 9.74% | 3.90% | 20.85% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $22.81B | 10.52 | 10.19% | 0.37% | -2.36% | -0.42% |